SSRP1 and cancer: Moreover, we found the FACT inhibitor, CBL0137, to be a promising viral sensitizer that improved VSVΔM51 replication in these and other human cancer lines known to be resistant to infection by VSVΔM51/VSVM51R oncolytic strains.